Literature DB >> 18206274

After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatment.

Michael Bröker1, Herwig Kollaritsch.   

Abstract

If a person suffers a tick bite in tick-borne encephalitis (TBE) endemic areas, there is uncertainty on post-exposure treatment of naïve (non-immune) persons in order to protect the patient against TBE. Particularly, there are no distinct positions on the use of TBE active immunization as post-exposure treatment. Of special concern is the possibility of antibody-dependent enhancement of infection and exacerbation of disease in case of post-exposure vaccination. Such phenomena have been reported for other flavivirus infections. In the past, immune globulin treatment was recommended, but these preparations are no longer available. Active immunization by using the current immunization schedules after a tick bite will not result in appropriate neutralizing antibody concentrations within due time. Based on the assumptions that vaccination is not quick acting enough after a tick bite and that the theoretical risk of antibody-dependent enhancement cannot be excluded, no vaccination or other specific measure is currently recommended after a tick bite in non-vaccinated patients, leaving the patient in a completely dissatisfactory position. A risk/benefit analysis has been re-assessed for persons with a history with at least one vaccine injection, certain patient groups and in relation to the vaccination schedule which has been used and to the geographic area where the tick bite has occurred. In order to evaluate the value of the vaccine for post-exposure immunization, new immunization schedules have to be evaluated with respect to their capacity to induce antibodies more quickly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18206274     DOI: 10.1016/j.vaccine.2007.11.046

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

Review 1.  Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management.

Authors:  Petra Bogovic; Franc Strle
Journal:  World J Clin Cases       Date:  2015-05-16       Impact factor: 1.337

Review 2.  Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.

Authors:  Marie Studahl; Lars Lindquist; Britt-Marie Eriksson; Göran Günther; Malin Bengner; Elisabeth Franzen-Röhl; Jan Fohlman; Tomas Bergström; Elisabeth Aurelius
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

3.  Acaricidal properties of ylang-ylang oil and star anise oil against nymphs of Ixodes ricinus (Acari: Ixodidae).

Authors:  Fawzeia Elmhalli; Katinka Pålsson; Jan Örberg; Giulio Grandi
Journal:  Exp Appl Acarol       Date:  2018-10-09       Impact factor: 2.132

Review 4.  Post-exposure prophylactic vaccine candidates for the treatment of human Risk Group 4 pathogen infections.

Authors:  James Logue; Ian Crozier; Peter B Jahrling; Jens H Kuhn
Journal:  Expert Rev Vaccines       Date:  2020-01-30       Impact factor: 5.683

5.  Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine.

Authors:  O Riede; K Seifert; D Oswald; A Endmann; C Hock; A Winkler; F J Salguero; M Schroff; S L Croft; C Juhls
Journal:  Gene Ther       Date:  2015-04-30       Impact factor: 5.250

6.  Tick-borne encephalitis: A 43-year summary of epidemiological and clinical data from Latvia (1973 to 2016).

Authors:  Dace Zavadska; Zane Odzelevica; Guntis Karelis; Lelde Liepina; Zane Anna Litauniece; Antra Bormane; Irina Lucenko; Jurijs Perevoscikovs; Linda Bridina; Laura Veide; Angelika Krumina; Jelena Storozenko; Wilhelm Erber; Myint Tin Tin Htar; Heinz-Josef Schmitt
Journal:  PLoS One       Date:  2018-11-13       Impact factor: 3.240

7.  Post-exposure administration of chimeric antibody protects mice against European, Siberian, and Far-Eastern subtypes of tick-borne encephalitis virus.

Authors:  Andrey L Matveev; Irina V Kozlova; Oleg V Stronin; Yana A Khlusevich; Elena K Doroshchenko; Ivan K Baykov; Oksana V Lisak; Ljudmila A Emelyanova; Olga V Suntsova; Vera A Matveeva; Julia S Savinova; Nina V Tikunova
Journal:  PLoS One       Date:  2019-04-08       Impact factor: 3.240

8.  Therapeutic effect of post-exposure treatment with antiserum on severe fever with thrombocytopenia syndrome (SFTS) in a mouse model of SFTS virus infection.

Authors:  Satoshi Shimada; Guillermo Posadas-Herrera; Kotaro Aoki; Kouichi Morita; Daisuke Hayasaka
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

9.  Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses.

Authors:  Laura A VanBlargan; John M Errico; Natasha M Kafai; Katherine E Burgomaster; Prashant N Jethva; Rebecca M Broeckel; Kimberly Meade-White; Christopher A Nelson; Sunny Himansu; David Wang; Scott A Handley; Michael L Gross; Sonja M Best; Theodore C Pierson; Daved H Fremont; Michael S Diamond
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 17.579

10.  Correlation of TBE incidence with red deer and roe deer abundance in Slovenia.

Authors:  Nataša Knap; Tatjana Avšič-Županc
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.